U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
186091186091Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal FunctionSuspendedNo Results AvailableKidney Failure, AcuteProcedure: controlling the MAPhttps://ClinicalTrials.gov/show/NCT00117416
186092186092Anti-Oxidant Treatment of Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: Vitamin E, Vitamin C, and Alpha-lipoic Acid|Drug: Coenzyme Q|Drug: Placebo capsules|Drug: Placebo wafershttps://ClinicalTrials.gov/show/NCT00117403
186093186093Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill PatientsCompletedNo Results AvailableRenal Function|Critical IllnessProcedure: Measurement of inulin clearancehttps://ClinicalTrials.gov/show/NCT00117390
186094186094Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic DermatitisCompletedNo Results AvailableAtopic DermatitisDrug: Pimecrolimus|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00117377
186095186095Effect of SACCHACHITIN on Healing of a Chronic WoundRecruitingNo Results AvailableWoundsDrug: SACCHACHITIN patchhttps://ClinicalTrials.gov/show/NCT00117364
186096186096VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC FeaturesTerminatedNo Results AvailableCarcinoma, Non-Small-Cell Lung|Adenocarcinoma, Bronchiolo-AlveolarDrug: VELCADEhttps://ClinicalTrials.gov/show/NCT00117351
186097186097A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)CompletedHas ResultsAsthmaDrug: montelukast sodium|Drug: Comparator: placebo (unspecified)https://ClinicalTrials.gov/show/NCT00117338
186098186098Study Of Adults And Adolescents With Vasomotor RhinitisCompletedNo Results AvailableVasomotor Rhinitis|Rhinitis, VasomotorDrug: GW685698Xhttps://ClinicalTrials.gov/show/NCT00117325
186099186099Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsTerminatedHas ResultsProstate CancerDrug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelixhttps://ClinicalTrials.gov/show/NCT00117312
186100186100PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to ImatinibCompletedNo Results AvailableSarcomaDrug: PTK787/ZK222584https://ClinicalTrials.gov/show/NCT00117299
186101186101Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate CancerCompletedHas ResultsProstate CancerDrug: Degarelixhttps://ClinicalTrials.gov/show/NCT00117286
186102186102A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive RegimensCompletedNo Results AvailableHealthyDrug: Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)]|Drug: Seasonique (LNG/EE and EE)|Drug: Portia (LNG/EE)https://ClinicalTrials.gov/show/NCT00117273
186103186103Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral DensityWithdrawnNo Results AvailableOsteopeniaDrug: Seasonale (levonorgestrel and ethinyl estradiol)https://ClinicalTrials.gov/show/NCT00117260
186104186104A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control SubjectsCompletedNo Results AvailableAnemia|Congestive Heart FailureDrug: darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00117247
186105186105Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and AnemiaCompletedNo Results AvailableCongestive Heart Failure|AnemiaDrug: darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00117234
186106186106MRI Measurement of Brain Metabolism Across the Sleep-Wake CycleCompletedNo Results AvailableSleephttps://ClinicalTrials.gov/show/NCT00117221
186107186107Comparison of Inhaled Mannitol and rhDNase in Children With Cystic FibrosisCompletedNo Results AvailableCystic FibrosisDrug: mannitol|Drug: mannitol + pulmozyme|Drug: Dornase alphahttps://ClinicalTrials.gov/show/NCT00117208
186108186108A Study of Neurophysiologic Changes in Individuals With Parkinson's DiseaseCompletedNo Results AvailableParkinson's Disease|Parkinsonian SyndromeDevice: Automated Neuropsychological Assessment Matrixhttps://ClinicalTrials.gov/show/NCT00117195
186109186109Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPDCompletedNo Results AvailableLung Diseases, ObstructiveDrug: Dry powder mannitol|Drug: Budesonide 400mcg administered via turbuhaler|Drug: Ipratropium bromide 80mcg|Drug: Salbutamol 400mcghttps://ClinicalTrials.gov/show/NCT00117182
186110186110Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary EmbolismCompletedNo Results AvailablePulmonary EmbolismProcedure: multi-detector helical computed tomographyhttps://ClinicalTrials.gov/show/NCT00117169
186111186111Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's LymphomaCompletedHas ResultsLymphoma, Non-Hodgkin|MALT LymphomaDrug: Fludarabine|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00117156
186112186112Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)CompletedNo Results AvailableThrombocytopenic PurpuraDrug: AMG 531https://ClinicalTrials.gov/show/NCT00117143
186113186113Study to Evaluate Effectiveness of Aranesp®CompletedNo Results AvailableKidney DiseaseDrug: Aranesp®https://ClinicalTrials.gov/show/NCT00117130
186114186114A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®CompletedNo Results AvailableAnemiaDrug: Aranesphttps://ClinicalTrials.gov/show/NCT00117117
186115186115Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic HemodialysisCompletedNo Results AvailableEnd Stage Renal DiseaseDrug: Aranesp®https://ClinicalTrials.gov/show/NCT00117104
186116186116Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)CompletedNo Results AvailableRheumatoid ArthritisDrug: Anakinra (Kineret®)https://ClinicalTrials.gov/show/NCT00117091
186117186117Aranesp® Monthly Preference Study - 2CompletedNo Results AvailableKidney DiseaseDrug: Aranesp®https://ClinicalTrials.gov/show/NCT00117078
186118186118Study of Transplant Related Anemia Treated With Aranesp® (STRATA)CompletedNo Results AvailableAnemiaDrug: Aranesp®https://ClinicalTrials.gov/show/NCT00117065
186119186119SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary HyperparathyroidismCompletedNo Results AvailableSecondary Hyperparathyroidism|End Stage Renal DiseaseDrug: cinacalcethttps://ClinicalTrials.gov/show/NCT00117052
186120186120A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With AnemiaCompletedNo Results AvailableAnemia|NeoplasmsDrug: Aranesp®https://ClinicalTrials.gov/show/NCT00117039

* Görseller ve İçerik tekif hakkına sahip olabilir